Smart strategies for risk reduction in type 2 diabetes
| Saturday, May 3, 2025 |
| 3:00 PM - 3:30 PM |
| Grand Ballroom |
| Sponsored By: |
Overview
Joanne Gross
Details
Explore evidence-based approaches to managing risks in patients with Type 2 Diabetes (T2D). This session will delve into current recommendations and therapeutic interventions aimed at reducing cardiovascular and renal complications, offering practical insights for pharmacists to enhance patient outcomes.
Learning objectives:
1. Identify the interconnected risks of cardiovascular and renal complications in patients with T2D.
2. Discuss pharmacological and non-pharmacological strategies for mitigating cardiorenal risks.
3. Recognise evidence-based guidelines to optimise patient-specific management plans for cardiorenal health in T2D.
Competency standards (2016): 1.6, 3.5
Speaker
Ms Joanne Gross
QUM Pharmacist
Department of Health Tasmania
Smart strategies for cardiorenal risk reduction in type 2 diabetes
Biography
Joanne is a Quality Use of Medicines (QUM) Pharmacist at the Department of Health Tasmania, an HMR-credentialed pharmacist and current PSA Tasmania Branch Vice President.
Joanne previously worked in Cardiology and Coronary Care Units at the Royal North Shore hospital in Sydney and served on the SHPA Cardiology Specialty Practice Leadership Committee. Joanne has worked in Medical Information and Pharmacovigilance for Boehringer Ingelheim and their diabetes medicines and has delivered several cardiovascular and kidney disease educational visiting programs to hundreds of health professionals as a previous NPS MedicineWise educational visitor.
